Sunday’s morning session (October 2) of the ASEMV/AAEV 2022 Annual Meeting in Asilomar, California consisted of five 20-minute presentations and four 5-minute short presentations. The 20-minute presentations included Lane Christenson discussing “Mapping EV Release and Uptake Using Multiple Cre Promoters in Mice;” Yong Woo Cho of Hangyang University in Korea speaking on “Taking Exosome Therapeutics from Bench to Bedside;” Jared Lynch of iZOD describing “Paving the Way to Automation and Standardization for Scalable Isolation of EVs;” Sushrut Kamerkar of Codiak BioSciences speaking on how “Exosome-Mediated Delivery of Antisense Oligonucleotides Reprograms Tumor-Associated Macrophages and Induces Anti-Tumor Responses;” and Frederik Verweij of Utrecht University, The Netherlands discussing “Exploiting CD63-Based Reporter Systems to Image EV Release in Vitro and in Vivo.”